Comprehensive guide to stem cell therapy for knee osteoarthritis, cartilage repair, and sports injuries. PRP vs stem cells comparison, recovery timelines, and outcomes.
Articular cartilage has minimal self-repair capacity. MSC therapy addresses knee osteoarthritis through direct cartilage regeneration (MSCs differentiating into chondrocytes), reduction of inflammatory mediators (IL-1β, TNF-α) driving cartilage breakdown, and paracrine stimulation of local progenitor cells. Multiple MRI-based studies confirm measurable cartilage thickness increases after MSC treatment.
Published meta-analyses of randomized controlled trials (2024 data) show 70-85% of knee OA patients report meaningful improvement in pain, function, and quality of life after MSC therapy. VAS pain scores and KOOS functional scores show statistically significant improvements versus control groups. Cartilage thickness improvements are measurable on MRI at 6-12 months.
Best candidates have Kellgren-Lawrence grades I-III knee osteoarthritis, are under 70 years of age, have moderate-to-severe pain affecting quality of life, and have not responded adequately to conservative treatment. Patients with bone-on-bone (grade IV) OA may need realistic expectations and may still benefit from delaying knee replacement.
Related articles: Understanding Stem Cell Therapy (2026 Complete Guide) | Exosome Therapy Benefits (2026 Research Update) | Is Stem Cell Therapy Safe? Understanding Risks, Benefits & Evidence
Related treatments: Osteoarthritis Stem Cell Therapy | Sports Injury Stem Cell Therapy | Rheumatoid Arthritis Stem Cell Therapy